Lunch workshop at the American Association for the Advancement of Science (AAAS) Annual Meeting

02/06/04

Anti-interferon Beta Antibodies in MS Care: A Consensus

*** ATTENTION SCIENCE WRITERS ATTENDING THE NASW CONFERENCE ***

LUNCH WORKSHOP AT THE AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE (AAAS) ANNUAL MEETING

WHAT:

An educational lunch workshop, "Anti-interferon Beta Antibodies in MS Care: A Consensus," featuring world-renowned neurology experts who will explore the issue of neutralizing antibodies (NAbs). The discussion will focus on:

  • Challenges in multiple sclerosis care and research
  • The model of the Consortium of Multiple Sclerosis Centers (CMSC) in meeting these challenges
  • Previous consensus conferences utilizing this model
  • The issue of anti-interferon beta antibodies in multiple sclerosis
  • Overview of additional therapeutic categories impacted by NAbs (anemia, diabetes, growth hormone deficiency)
  • NAbs in the treatment of multiple sclerosis: global consensus development

    WHY:

    The advent of biologics (protein-based medications) has benefited countless patients with chronic diseases including cancer, anemia, diabetes, rheumatoid arthritis, psoriasis and multiple sclerosis.

    However, there has been an unexpected consequence: the development of NAbs, in which the body perceives protein-based therapies to be foreign and mounts an immune response against them. As treatment with biologics increases, the hot debate continues about whether NAbs are just innocent immunological bystanders or a natural defense mechanism that diminishes the efficacy of biologic therapies. Professionals need expert synthesis and consensus.

    This program will outline in workshop style how a consensus was developed by the CMSC, the leading professional association in multiple sclerosis care.

    WHO:

    Frederick Munschauer, MD, Chair, Department of Neurology, SUNY at Buffalo School of Medicine and Chief, The Jacobs Neurological Institute, Buffalo General Hospital, Buffalo, New York; Secretary of the Board of Governors, CMSC, and the Co-Chair of the CMSC Cooperative Studies Group in Multiple Sclerosis

    Andrew R. Pachner, MD, Professor of Neurology and Neurosciences, Department of Neurosciences, University of Medicine & Dentistry of New Jersey, Newark, New Jersey

    WHEN:

    Saturday, February 14, 2004
    121:30 p.m.

    WHERE:

    Convention Center Exhibit Hall 4C, Workshop Room D
    Washington State Convention & Trade Center
    800 Convention Place
    Seattle, WA

    CONTACT:

    Cindy Gessell 201-652-4778 or Amy Losak 646-935-3917

    This workshop is sponsored by the Consortium of Multiple Sclerosis Centers (CMSC)

    Source: Eurekalert & others

    Last reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
        Published on PsychCentral.com. All rights reserved.

     

     

    Adversity introduces a man to himself.
    ~ Albert Einstein
  •